NL-OMON38889撤回不适用
Effects of cholestasis on pharmacokinetics - Cholestase and pharmacokinetics
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Bilirubin > 50 mmol/l, caused by posthepatic biliary obstruction
- •- Endoscopic Retrograde CholangioPancreatography (ERCP) has been scheduled
- •- > 18 years old
排除标准
- •- Diabetes Mellitus (both type 1 and 2)
- •- Cholangitis
- •- If a significant change in use of medication after ERCP is to be expected
- •- Use of omeprazole, warfarin, metoprolol, caffeine or midazolam (= medication of our probe cocktail) as standard treatment
- •- Use of herbal medicine or medication that inhibits or induces CYP3A4/5, CYP2C9, CYP1A2, CYP2C19, CYP2D6
研究者
相似试验
进行中（未招募）
1 期
Exploratory evaluation of the effect of cholestyramine on serum levels of persistent organic pollutants in obese patientsObesityCTIS2023-505116-37-00Centre Hospitalier Universitaire De Nice20
已完成
不适用
Clinical study of the correlation between cholesterol absorption and coronary risk factors or arteriosclerotic diseases, and of the clinical significance of the controlling cholesterol absorption.HypercholesterolemiaJPRN-UMIN000001718eurology, Respirology, Endocrinology and Metabolism, Miyazaki Medical College, University of Miyazaki200
招募中
不适用
The clinical study of correlation between cholesterol-lowering therapy and the progression of atherosclerosis in type 2 diabetes mellitusJPRN-UMIN000015925Human Ethics Review Committee of Kumamoto University200
尚未招募
4 期
Role of Vitamin D in heart and kidney DiseaseCTRI/2019/10/021494Indian Council of Medical Research
已完成
4 期
Therapeutic effects of cholesterol absorption inhibitor on renal function in patients with chronic kidney diseaseChronic kidney disease HypercholesterolemiaJPRN-UMIN000002528Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine50